[18F]-olaparib PET; Molecular imaging of DNA damage response by [18F]-olaparib PET
19310
Phase 2 other active
Quick answer
[18F]-olaparib PET; Molecular imaging of DNA damage response by [18F]-olaparib PET for Head and neck squamous cell carcinoma (HNSCC) is a Phase 2 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Head and neck squamous cell carcinoma (HNSCC)
- Phase
- Phase 2
- Modality
- other
- Status
- active